Munich Reinsurance Co Stock Corp in Munich Trims Stake in Cigna Group $CI

Munich Reinsurance Co Stock Corp in Munich cut its position in Cigna Group (NYSE:CI) by 59.1% in the second quarter, Holdings Channel reports. The firm owned 15,536 shares of the health services provider’s stock after selling 22,418 shares during the period. Munich Reinsurance Co Stock Corp in Munich’s holdings in Cigna Group were worth $4,283,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in CI. Wilkerson Advisory Group LLC acquired a new stake in shares of Cigna Group in the fourth quarter valued at approximately $25,000. Osbon Capital Management LLC purchased a new stake in Cigna Group in the 2nd quarter valued at $26,000. Johnson Financial Group Inc. purchased a new stake in Cigna Group in the 2nd quarter valued at $29,000. Kemnay Advisory Services Inc. acquired a new position in Cigna Group in the fourth quarter valued at $29,000. Finally, Prosperity Bancshares Inc acquired a new stake in shares of Cigna Group during the fourth quarter worth about $29,000. Hedge funds and other institutional investors own 86.99% of the company’s stock.

Insider Buying and Selling

In related news, CAO Jamie G. Kates sold 899 shares of the firm’s stock in a transaction that occurred on Friday, June 12th. The stock was sold at an average price of $298.61, for a total value of $268,450.39. Following the completion of the transaction, the chief accounting officer directly owned 2,368 shares of the company’s stock, valued at $707,108.48. This trade represents a 27.52% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, insider Nicole S. Jones sold 2,677 shares of the business’s stock in a transaction on Tuesday, August 18th. The stock was sold at an average price of $279.61, for a total value of $748,515.97. Following the sale, the insider owned 25,880 shares in the company, valued at approximately $7,236,306.80. The trade was a 9.37% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last quarter, insiders have sold 23,012 shares of company stock valued at $6,386,550. Insiders own 0.60% of the company’s stock.

Analyst Ratings Changes

Several analysts have commented on CI shares. Deutsche Bank Aktiengesellschaft downgraded Cigna Group from a “buy” rating to a “hold” rating and reduced their price objective for the company from $303.00 to $302.00 in a research note on Wednesday, May 20th. Robert W. Baird set a $362.00 price target on Cigna Group in a report on Friday, July 31st. Wall Street Zen upgraded shares of Cigna Group from a “hold” rating to a “buy” rating in a research report on Saturday, August 29th. Raymond James Financial cut shares of Cigna Group from a “strong-buy” rating to an “outperform” rating and dropped their price objective for the company from $350.00 to $320.00 in a research note on Monday, August 3rd. Finally, Piper Sandler reduced their target price on shares of Cigna Group from $370.00 to $346.00 and set an “overweight” rating for the company in a research note on Wednesday, June 3rd. Fifteen analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $339.45.

Cigna Group Stock Down 1.4%

CI opened at $282.24 on Friday. The company has a debt-to-equity ratio of 0.68, a current ratio of 0.76 and a quick ratio of 0.76. The business has a 50 day simple moving average of $283.51 and a 200-day simple moving average of $281.07. The stock has a market capitalization of $74.58 billion, a P/E ratio of 11.68, a P/E/G ratio of 0.98 and a beta of 0.31. Cigna Group has a 12 month low of $239.51 and a 12 month high of $315.47.

Cigna Group (NYSE:CI) last posted its quarterly earnings results on Thursday, July 30th. The health services provider reported $7.78 earnings per share for the quarter, topping analysts’ consensus estimates of $7.60 by $0.18. The business had revenue of $70.04 billion for the quarter, compared to analysts’ expectations of $70.14 billion. Cigna Group had a net margin of 2.27% and a return on equity of 19.75%. The business’s revenue for the quarter was up 6.7% on a year-over-year basis. During the same period in the prior year, the company posted $7.20 EPS. Cigna Group has set its FY 2026 guidance at 30.450- EPS. On average, equities analysts anticipate that Cigna Group will post 30.51 earnings per share for the current fiscal year.

Cigna Group Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Wednesday, September 23rd. Shareholders of record on Tuesday, September 8th will be issued a $1.56 dividend. The ex-dividend date of this dividend is Tuesday, September 8th. This represents a $6.24 dividend on an annualized basis and a yield of 2.2%. Cigna Group’s dividend payout ratio (DPR) is 25.82%.

About Cigna Group

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.